Long-acting bronchodilators in COPD: an evolving story

被引：1
|
作者：
Martinez, Fernando J. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
LANCET RESPIRATORY MEDICINE | 2013年 / 1卷 / 07期
关键词：
TIOTROPIUM; INDACATEROL;
D O I：
10.1016/S2213-2600(13)70177-2
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：499 / 501
页数：4
相关论文
共 50 条
  • [31] Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients
    Decramer, Marc
    Maltais, Francois
    Feldman, Gregory
    Brooks, Jean
    Harris, Stephanie
    Mehta, Rashmi
    Crater, Glenn
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2013, 185 (02) : 393 - 399
  • [32] Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan
    Yamada, Hideyasu
    Hida, Norihito
    Hizawa, Nobuyuki
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3141 - 3147
  • [33] Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis
    Wang, J.
    Nie, B.
    Xiong, W.
    Xu, Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (02) : 204 - 211
  • [34] Low Doses of Long-Acting β-Agonists/Long-Acting Muscarinic Agents with Large Effects The FLIGHT Study
    Donohue, James F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (09) : 1028 - 1030
  • [35] Nasally delivered drugs (corticosteroids and vaccines), ultra long-acting bronchodilators and inhaled therapies in an animal model
    Boubaya, A.
    Pruliere-Escabasse, V.
    Gaudelus, J.
    Roche, N.
    Vanneph, V.
    Dubus, J. -C.
    REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (06) : 608 - 617
  • [36] Onset of Effect of Aclidinium, a Novel, Long-Acting Muscarinic Antagonist, in Patients with COPD
    Vestbo, Jorgen
    Vogelmeier, Claus
    Creemers, Jacques
    Falques, Meritxell
    Ribera, Anna
    Gil, Esther Garcia
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010, 7 (05) : 331 - 336
  • [37] The role of combination inhaled corticosteroid/long-acting β-agonist therapy in COPD management
    Mapel, Douglas W.
    Hurley, Judith S.
    Dalal, Anand A.
    Blanchette, Christopher M.
    PRIMARY CARE RESPIRATORY JOURNAL, 2010, 19 (02): : 93 - 103
  • [38] Which long-acting bronchodilator is most cost-effective for the treatment of COPD?
    Hoogendoorn, M.
    Kappelhoff, B. S.
    Overbeek, J. A.
    Wouters, E. F. M.
    Rutten-van Molken, M. P. M. H.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (08) : 357 - 364
  • [39] Role of Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Therapy in Chronic Obstructive Pulmonary Disease
    Petite, Sarah E.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (08) : 696 - 705
  • [40] Long acting muscarinic antagonists vs. long-acting β2 agonists in COPD exacerbations: a systematic review and meta analysis
    Maia, Israel Silva
    Pincellii, Mariangela Pimentel
    Leite, Victor Figueiredo
    Amadera, Joao
    Buehler, Anna Maria
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2017, 43 (04) : 302 - 312
12345